18 studies on Dsip curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab currently tracks 908 published third-party lab tests of Dsip across 423 identified manufacturers. Among reports with a positive numeric purity result, the average is 99.24%. Within this published corpus, 2 positive purity results were below 90%, and 67 reports showed measured quantity more than 10% below the label claim. These are batch-level observations, not guarantees of product identity, safety, or vendor quality.
As of 2026-09-03, vendor-blind retail asking-price averages for the US delivery market, calculated from the same in-stock exact-strength cells as the Peptide Price Index. Shipping is excluded.
| Strength | Average / vial | Observed range / vial | Average / mg | Coverage |
|---|---|---|---|---|
| 2 mg | $5.50 | $5.50–$5.50 | $2.75 | 1 source · 1 offer |
| 5 mg | $7.50 | $6.50–$8.00 | $1.50 | 4 sources · 4 offers |
| 10 mg | $9.50 | $5.50–$11.50 | $0.95 | 6 sources · 6 offers |
Asking prices are not manufacturing cost and do not establish product equivalence, quality, safety, or legality. The refresh date is the catalog build date; individual source observation dates are not available in this snapshot. View full price methodology →
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
Within that total, 173 batches have unresolved manufacturer identity. They remain in corpus-level lab evidence and are excluded from named-manufacturer rankings.
Eligible vendors have at least 2 deduplicated tests and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and test count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes tested batches, not every product or shipment, and is not an endorsement.
| Rank | Manufacturer | Tests | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 22 | 99.48% | 0 of 18 (0.0%) 0 0% / not detected · 0 wrong compound · 4 unclassified | Reveal with Pro → | |
| #2 | 16 | 99.63% | 0 of 16 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #3 | 9 | 98.08% | 0 of 9 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → |
Manufacturer identities are included with Pro. Batch counts and lab measurements remain visible.
Recent certificates: #100836 (99.18%) · #100204 (99.77%) · #100081 (99.03%) · #99545 (99.43%) · #100287 (99.49%) · #100348 (99.01%)
For **automotive engineers and system designers**, optimizing FlexRay message scheduling is critical for ensuring the stability and real-time performance of intelligent connected vehicles. Improved bandwidth utilizati…
This review highlights that polyamines represent a significant and underexplored therapeutic avenue for addressing cognitive impairment in various neurological and psychiatric conditions. Understanding their complex m…
This study represents a significant advancement towards more robust and accessible Alzheimer's disease diagnosis, especially in clinical environments where acquiring a full suite of neuroimaging data is frequently imp…
These findings are significant as they highlight delta sleep-inducing peptide (DSIP) as a potential therapeutic agent for mitigating stress-induced liver damage and dysfunction. The observed normalization of oxidative…
This research highlights the hepatoprotective potential of Delta Sleep-Inducing Peptide (DSIP), particularly in mitigating liver damage caused by chronic psychological stress. The findings suggest that DSIP could be a…
This research is highly significant because it establishes a robust, efficient, and scalable method for producing a modified Delta Sleep-Inducing Peptide (DSIP) with enhanced pharmacokinetic properties. The successful…
The study found that p-DSIP treatment significantly improved sleep architecture in high-altitude exposed rats, leading to a marked increase in non-rapid eye movement (NREM) sleep duration and a significant reduction i…
This research significantly advances our understanding of the fundamental molecular mechanisms underlying precise neural circuit formation. By identifying DIP-α and Dpr10 as key transsynaptic organizers, the study pro…
This review significantly enhances forensic intelligence capabilities, providing law enforcement agencies with updated tools to track the origin and manufacturing methods of seized methamphetamine. Understanding these…
This research provides crucial insights into the complex socio-economic and technical barriers faced by low-income communities in accessing improved sanitation infrastructure. The findings are vital for informing effe…
This research highlights the DSIP-Like KND Peptide as a promising candidate for mitigating ischemia-reperfusion injury in both cerebral and cardiac tissues. The ability to reduce infarct size during the reperfusion wi…
This study provides compelling evidence that Delta Sleep-Inducing Peptide (DSIP) can significantly promote motor function recovery and reduce brain damage following ischemic stroke. The observed improvements in neurol…
These findings are crucial for optimizing clinical protocols for neonatal jaundice management. Demonstrating that double-surface phototherapy is more efficient without compromising safety could lead to its broader ado…
This research represents a significant advancement in sustainable peptide chemistry, providing a greener and more efficient route for producing peptide pharmaceuticals and biomaterials. By drastically reducing chemica…
This research represents a significant advancement by demonstrating a scalable and efficient method for producing therapeutic peptides that can effectively overcome the formidable challenge of the blood-brain barrier.…
Free, no account — handy when you're working with Dsip.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$12 monthly or $33 lifetime
Create free account